Replies to post #72 on Nuvectra Corp. (fka NVTRQ)

[joseytheoutlawwales]

It's a battlefield in the stim market right now, and MRI ability is one of the points of contention.

Nuvectra will be conditional for extremity only; and depends upon where the device is placed in the spine (typical for all companies).

Medtronic has full-body with their main device (as well as the new Intellis system that will hopefully be approved this year by FDA).

Boston has a full-body device, but it's larger; i.e. Possible patient discomfort. Their Spectra is conditional for head only.

So Nuvectra's move is a GOOD one, stays competitive.